Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6734468 | 7394929 | I | 6734468-2 | 20100506 | 20100520 | EXP | US-ELI_LILLY_AND_COMPANY-US201005002897 | ELI LILLY AND COMPANY | YR | F | Y | 20100518 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6734468 | 1013724248 | PS | FORTEO | 1 | 20 UG, DAILY (1/D) | 021318 | |||||
| 6734468 | 1013724249 | C | FOSAMAX | 1 | 75 MG, WEEKLY (1/W) | ||||||
| 6734468 | 1013724250 | C | CLIMARA | 1 | TRANSDERMAL | UNK, WEEKLY (1/W) | |||||
| 6734468 | 1013724251 | C | AMITRIPTLINE HYDROCHLORIDE TAB | 1 | 25 MG, EACH EVENING | ||||||
| 6734468 | 1013724252 | C | LISINOPRIL | 1 | 10 MG, DAILY (1/D) | ||||||
| 6734468 | 1013724253 | C | CRESTOR /01588602/ | 2 | 10 MG, DAILY (1/D) | ||||||
| 6734468 | 1013724254 | C | CRANBERRY | 2 | |||||||
| 6734468 | 1013724255 | C | ASPIRIN | 1 | 325 MG, UNKNOWN | ||||||
| 6734468 | 1013724256 | C | OSCAL /00108001/ | 2 | |||||||
| 6734468 | 1013724257 | C | MACROBID | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6734468 | 1013724248 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6734468 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6734468 | BREAST CANCER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6734468 | 1013724248 | 20090301 |